FDA NDC Directory · JSON-LD · Markdown
NDC 0006-5083 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION
| Generic name | pembrolizumab and berahyaluronidase alfa-pmph |
|---|---|
| Labeler / Manufacturer | Merck Sharp & Dohme LLC |
| Marketing category | Biologic License Application · App BLA761467 |
| Dosage form / route | INJECTION, SOLUTION · SUBCUTANEOUS |
| Active ingredients | BERAHYALURONIDASE ALFA (2000 U/mL) PEMBROLIZUMAB (165 mg/mL) |
| Marketing started | 20250919 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).